On February 13, 2026, Mainz Biomed N.V. (the “Company”) entered into a securities purchase agreement for a 6.0 USD million private placement with investor David Lazar. The financing will be completed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results